MRX-825

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMRX-825
Drug Alias Nametargeted perfluorocarbone nanodroplets (ImaRx)MRX-825
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIschemiaHeart FailureStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImarx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImarx Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsIschemiaHeart FailureStroke

Other Information

ATC CodeN/A
Related LinksN/A